Abstract
CYTOGENETIC abnormalities of chromosome 9p21 are characteristic of malignant melanomas1,2, gliomas3, lung cancers4 and leukaemias5. From a panel of 46 human malignant cell lines, we localized by positional cloning the most frequently deleted region on 9p21. Sequence analysis of the isolated fragment reveals two open reading frames identical to the recently described complementary DNA for the inhibitor of cyclin-dependent kinase 4 (CDK4) 6. Polymerase chain reaction and Southern blot analysis confirmed the frequent deletion or rearrangement of the CDK4-inhibitor gene in melanomas, gliomas, lung cancers and leukaemias, and the absence of detectable gene transcripts. One carcinoma had a deletion entirely within the CDK4-inhibitor gene. The CDK4-inhibitor gene from a patient with dysplastic nevus syndrome had a germ-line nonsense mutation. The CDK4 inhibitor is thought to be a physiological suppressor of proliferation. Cells unable to produce the inhibitor may be prone to neoplastic transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fountain, J. E. et al. Proc. natn. Acad. Sci. U.S.A. 89, 10557–10561 (1992).
Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
Olopade, O. I. et al. Cancer Res. 52, 2523–2529 (1992).
Olopade, O. I. et al. Cancer Res. 53, 2410–2415 (1993).
Olopade, O. I. et al. Genomics 14, 437–443 (1992).
Serrano, M., Hannon, G. J. & Beach, D. Nature 366, 704–707 (1993).
Nobori, T. et al. Cancer Res. 51, 3193–3197 (1991).
Nobori, T. et al. Cancer Res. 53, 1098–10101 (1993).
Pierce, J. C. & Sternberg, N. L. Meth. Enzym. 216, 549–574 (1992).
Marx, J. Science 263, 319–321 (1994).
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. Cell 75, 805–816 (1993).
Xiong, Y. et al. Nature 366, 701–704 (1993).
Cannon-Albright, L. A. et al. Science 258, 1148–1152 (1992)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nobori, T., Miura, K., Wu, D. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994). https://doi.org/10.1038/368753a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/368753a0
This article is cited by
-
Amyloid formation and depolymerization of tumor suppressor p16INK4a are regulated by a thiol-dependent redox mechanism
Nature Communications (2024)
-
Combination therapy: synergism among three plant extracts against selected pathogens
BMC Research Notes (2023)
-
MicroRNA let-7 and viral infections: focus on mechanisms of action
Cellular & Molecular Biology Letters (2022)
-
Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism
Oncogene (2022)
-
Senescence and cancer — role and therapeutic opportunities
Nature Reviews Clinical Oncology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.